Climaco Law Cases
VIOXX
Merck & Co., Inc. recently announced a voluntary withdrawal of Vioxx (rofecoxib) from the U.S. and worldwide market due to safety concerns of an increased risk of cardiovascular events (including heart attack and stroke) in patients on Vioxx.
CELEBREX
On December 15, 2004 Pfizer Pharmaceutical announced that a recent study found an increased risk of heart disease with the pain killer Celebrex -- one of two U.S. approved Vioxx sister drugs.
BEXTRA
Following a request from the FDA, Pfizer Inc., on April 7, 2005 announced a voluntary withdrawal of Bextra from the U.S. and worldwide market due to safety concerns of an increased risk of Heart attacks, Strokes, Blood clots and a possibly life-threatening skin reactions known as Stevens Johnson Syndrome in patients taking Bextra.
DEFECTIVE PRODUCTS
Several recent high profile cases have revealed instances of neglect by manufacturing companies and facilities which exposed workers to hazardous materials and home owners to the dangers of toxic black mold. Now more than ever, workers and their families and consumers seek zealous representation in their claims damages.
ASBESTOS
Unfortunately, while the use of asbestos has been heavily restricted since the early 1970's, recent studies have estimated that its effects will continue to affect the health of asbestos workers, workers in industries who were exposed to asbestos and their families for years to come.
TOXIC WELDING FUMES
Fumes given off during welding contain high levels of Manganese, which can lead to Manganese Poisoning. Research studies also have indicated that there may be a substantially increased risk of Parkinson's disease and Parkinsonism caused by exposure to welding fumes.
GARFIELD ALLOYS EXPLOSION
Approximately 900 households were affected by the December 29, 2003 fire and explosion at the Garfield Heights, Ohio facility then owned and operated by Garfield Alloys, Inc.
